252 related articles for article (PubMed ID: 10686645)
1. [Transfusion of platelet concentrates].
Rieux C; Lee K; Lavaud A; Bierling P
Ann Med Interne (Paris); 1999 Dec; 150(8):631-41. PubMed ID: 10686645
[TBL] [Abstract][Full Text] [Related]
2. [Efficacy of leukocyte-depleted platelet concentrates for prevention of HLA-alloimmunization in patients with frequent platelet transfusions: a prospective multi-institutional study using a polyester platelet filter].
Handa M; Ikeda Y; Kurata Y; Tsubaki K; Horiuchi A; Furihata K; Kimura Y; Toyama K; Takamoto S; Tsukimoto I
Rinsho Ketsueki; 1992 Apr; 33(4):451-60. PubMed ID: 1602608
[TBL] [Abstract][Full Text] [Related]
3. [The effect of HLA alloimmunization and other factors on the effectiveness of thrombocyte concentrates].
Pittrová H; Koza V; Cepelák V; Bufková D
Cas Lek Cesk; 1990 Jun; 129(24):751-3. PubMed ID: 2393882
[TBL] [Abstract][Full Text] [Related]
4. Donor selection in platelet transfusion therapy of alloimmunized thrombocytopenic patients.
Duqesnoy RJ
Prog Clin Biol Res; 1978; 28():229-43. PubMed ID: 88057
[No Abstract] [Full Text] [Related]
5. [Prevention of HLA-alloimmunization of recipients of platelet concentrates].
Kuntz BM; Wollenhaupt HJ; Brüster HT
Beitr Infusionsther; 1991; 28():209-12. PubMed ID: 1725621
[TBL] [Abstract][Full Text] [Related]
6. The challenge of platelet alloimmunization: management and prevention.
Kickler TS
Transfus Med Rev; 1990 Oct; 4(4 Suppl 1):8-18. PubMed ID: 2134640
[TBL] [Abstract][Full Text] [Related]
7. Role of HLA-C matching in histocompatible platelet transfusion therapy of alloimmunized thrombocytopenic patients.
Duquesnoy RJ; Filip DJ; Tomasulo PA; Aster RH
Transplant Proc; 1977 Dec; 9(4):1827-8. PubMed ID: 601843
[No Abstract] [Full Text] [Related]
8. Variable expression of w4 and w6 on platelets: possible relevance to platelet transfusion therapy of alloimmunized thrombocytopenic patients.
Duquesnoy RJ; Testin J; Aster RH
Transplant Proc; 1977 Dec; 9(4):1829-31. PubMed ID: 601844
[No Abstract] [Full Text] [Related]
9. [Refractory effect and alloimmunization after transfusion of thrombocytes].
Volkova RI; Agranenko VA
Gematol Transfuziol; 1992 Feb; 37(2):16-21. PubMed ID: 1426903
[TBL] [Abstract][Full Text] [Related]
10. Anti-HLA Class I alloantibodies in platelet transfusion refractoriness: From mechanisms and determinants to therapeutic prospects.
Couvidou A; Rojas-Jiménez G; Dupuis A; Maître B
Front Immunol; 2023; 14():1125367. PubMed ID: 36845153
[TBL] [Abstract][Full Text] [Related]
11. Platelet transfusions.
Kelton JG; Blajchman MA
Can Med Assoc J; 1979 Nov; 121(10):1353-8. PubMed ID: 391376
[TBL] [Abstract][Full Text] [Related]
12. Guidelines for platelet transfusions. British Committee for Standards in Haematology, Working Party of the Blood Transfusion Task Force.
Murphy MF; Brozovic B; Murphy W; Ouwehand W; Waters AH
Transfus Med; 1992 Dec; 2(4):311-8. PubMed ID: 1339584
[TBL] [Abstract][Full Text] [Related]
13. Platelet transfusion refractoriness due to HLA alloimmunization: Evolving paradigms in mechanisms and management.
Panch SR; Guo L; Vassallo R
Blood Rev; 2023 Nov; 62():101135. PubMed ID: 37805287
[TBL] [Abstract][Full Text] [Related]
14. Platelet transfusions: the problem of refractoriness.
Murphy MF; Waters AH
Blood Rev; 1990 Mar; 4(1):16-24. PubMed ID: 2182145
[TBL] [Abstract][Full Text] [Related]
15. Platelet transfusion therapy.
Slichter SJ
Hematol Oncol Clin North Am; 1990 Feb; 4(1):291-311. PubMed ID: 2179213
[TBL] [Abstract][Full Text] [Related]
16. Platelet replacement therapy: a clinical assessment.
Hester JP; McCredie KB; Freireich EJ
Prog Clin Biol Res; 1978; 28():281-93. PubMed ID: 752154
[No Abstract] [Full Text] [Related]
17. [Platelet pool versus single platelet donor].
Rev Fr Transfus Immunohematol; 1987 Nov; 30(4):293-319. PubMed ID: 2832927
[No Abstract] [Full Text] [Related]
18. [Immunological principles of transfusion of blood platelet and granulocyte concentrates].
Zupańska B
Acta Haematol Pol; 1979 Oct; 10(4):327-32. PubMed ID: 539356
[No Abstract] [Full Text] [Related]
19. Prevention of refractoriness and HLA-alloimmunization using filtered blood products.
Sniecinski I; O'Donnell MR; Nowicki B; Hill LR
Blood; 1988 May; 71(5):1402-7. PubMed ID: 3282572
[TBL] [Abstract][Full Text] [Related]
20. HLA alloimmunization with leukocyte concentrates from HLA-matched and HLA-non-matched donors in patients with Hunter's syndrome.
Kakaiya RM; Greenstein R; Pisciotto P; Slocum SK; Rosen D; Cable RG; Morse EE; Gainey A
Ann Clin Lab Sci; 1985; 15(5):435-40. PubMed ID: 3933403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]